Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer’s dementia and mild cognitive impairment: clinical and biomarker correlates.

References

• Allegri, R. F., Taragano, F. E., Krupitzki, H., Serrano, C. M., Dillon, C., Sarasola, D., … Sanchez, V. (2010). Role of cognitive reserve in progression from mild cognitive impairment to dementia. Dementia & Neuropsychologia, 4(1), 28–34.
   PubMedGoogle Scholar
• Araujo, J. R., Martel, F., Borges, N., Araujo, J. M., & Keating, E. (2015). Folates and aging: Role in mild cognitive impairment, dementia and depression. Ageing Research Reviews, 22, 9–19.
   PubMed Web of Science ®Google Scholar
• Bailey, L. B., & Gregory, J. F. (1999). Folate metabolism and requirements. The Journal of Nutrition, 129(4), 779–782.
   PubMed Web of Science ®Google Scholar
• Balthazar, M. L., Cendes, F., & Damasceno, B. P. (2008). Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: Is there semantic disruption? Neuropsychology, 22(6), 703–709.
   PubMed Web of Science ®Google Scholar
• Bayles, K. A., & Tomoeda, C. K. (1983). Confrontation naming impairment in dementia. Brain and Language, 19(1), 98–114.
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., … Bienias, J. L. (2003). Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology, 60(2), 246–252.
   PubMed Web of Science ®Google Scholar
• Bodovitz, S., & Klein, W. L. (1996). Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. The Journal of Biological Chemistry, 271(8), 4436–4440.
   PubMed Web of Science ®Google Scholar
• Bowles, N. L., Obler, L. K., & Albert, M. L. (1987). Naming errors in healthy aging and dementia of the Alzheimer type. Cortex, 23(3), 519–524.
   PubMed Web of Science ®Google Scholar
• Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001). Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Archives of Neurology, 58(3), 411–416.
   PubMedGoogle Scholar
• Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends in Molecular Medicine, 7(12), 548–554.
   PubMed Web of Science ®Google Scholar
• Butterfield, D. A., & Lauderback, C. M. (2002). Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biology & Medicine, 32(11), 1050–1060.
   PubMed Web of Science ®Google Scholar
• Chandler, M. J., Lacritz, L. H., Hynan, L. S., Barnard, H. D., Allen, G., Deschner, M., … Cullum, C. M. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65(1), 102–106.
   PubMed Web of Science ®Google Scholar
• Chen, H., Liu, S., Ji, L., Wu, T., Ji, Y., Zhou, Y., … Huang, G. (2016). Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: A randomized controlled trial. Mediators of Inflammation, 2016, 5912146.
   PubMed Web of Science ®Google Scholar
• Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., … Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261(5123), 921–923.
   PubMed Web of Science ®Google Scholar
• Dal Forno, G., Rasmusson, D. X., Brandt, J., Carson, K. A., Brookmeyer, R., Troncoso, J., & Kawas, C. H. (1996). Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Archives of Neurology, 53(4), 345–350.
   PubMed Web of Science ®Google Scholar
• Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007). Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. Lancet, 369(9557), 208–216.
   PubMed Web of Science ®Google Scholar
• Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, Part XV. Neurology, 46(6), 1592–1596.
   PubMed Web of Science ®Google Scholar
• Ferrando, P. J., & Lorenzo-Seva, U. (2013). Unrestricted item factor analysis and some relations with item response theory. Technical Report.
   Google Scholar
• Ferrando, P. J., & Lorenzo-Seva, U. (2017). Manual of the program: FACTOR, Windows 7/Windows 8/Windows 10.
   Google Scholar
• Fillenbaum, G. G., van Belle, G., Morris, J. C., Mohs, R. C., Mirra, S. S., Davis, P. C., … Heyman, A. (2008). Consortium to establish a registry for Alzheimer's disease (CERAD): The first twenty years. Alzheimers & Dementia, 4(2), 96–109.
   PubMed Web of Science ®Google Scholar
• Fioravanti, M., Ferrario, E., Massaia, M., Cappa, G., Rivolta, G., Grossi, E., & Buckley, A. E. (1998). Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Archives of Gerontology and Geriatrics, 26(1), 1–13.
   PubMed Web of Science ®Google Scholar
• Fratiglioni, L., De Ronchi, D., & Aguero-Torres, H. (1999). Worldwide prevalence and incidence of dementia. Drugs Aging, 15(5), 365–375.
   PubMed Web of Science ®Google Scholar
• Frisoni, G. B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G., & Trabucchi, M. (1995). Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology, 37(5), 596–604.
   PubMed Web of Science ®Google Scholar
• Hall, J. R., Vo, H. T., Johnson, L. A., Wiechmann, A., & O’Bryant, S. E. (2012). Boston naming test: Gender differences in older adults with and without Alzheimer’s Dementia. Scientific Research, 3, 485–488.
   Google Scholar
• Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353–356.
   PubMed Web of Science ®Google Scholar
• He, Q., Li, Q., Zhao, J., Wu, T., Ji, L., Huang, G., & Ma, F. (2016). Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: A case-control study. Lipids in Health and Diseases, 15(1), 146.
   PubMedGoogle Scholar
• Helkala, E. L., Koivisto, K., Hanninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., … Riekkinen, P., Sr. (1995). The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters, 191(3), 141–144.
   PubMed Web of Science ®Google Scholar
• Hodges, J. R., Salmon, D. P., & Butters, N. (1991). The nature of the naming deficit in Alzheimer's and Huntington's disease. Brain, 114 (Pt 4), 1547–1558.
   PubMedGoogle Scholar
• Horwitz, J., & McCaffey, R. (2010). The boston naming test “noose” item: What is it good for? Archives of Clinical Neuropsychology, 25(6), 475–583.
   Web of Science ®Google Scholar
• Huff, F. J., Corkin, S., & Growdon, J. H. (1986). Semantic impairment and anomia in Alzheimer's disease. Brain and Language, 28(2), 235–249.
   PubMed Web of Science ®Google Scholar
• Kaplan E., Goodglass H., Weintraub S. (1983). The Boston Naming Test (2nd ed.) Philadelphia: Lea & Febiger.
   Google Scholar
• Karrasch, M., Sinerva, E., Gronholm, P., Rinne, J., & Laine, M. (2005). CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurologica Scandinavica, 111(3), 172–179.
   PubMed Web of Science ®Google Scholar
• Kim, G., Kim, H., Kim, K. N., Son, J. I., Kim, S. Y., Tamura, T., & Chang, N. (2013). Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: A cross-sectional survey. Journal of Alzheimer’s Disease, 33(3), 853–862.
   PubMed Web of Science ®Google Scholar
• Kim, H., Kim, G., Jang, W., Kim, S., & Chang, N. (2014). Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment. Nutrition Journal, 13, 118.
   PubMed Web of Science ®Google Scholar
• Kirshner, H. S., Webb, W. G., & Kelly, M. P. (1984). The naming disorder of dementia. Neuropsychologia, 22(1), 23–30.
   PubMed Web of Science ®Google Scholar
• Knesevich, J. W., LaBarge, E., & Edwards, D. (1986). Predictive value of the Boston Naming Test in mild senile dementia of the Alzheimer type. Psychiatry Research, 19(2), 155–161.
   PubMed Web of Science ®Google Scholar
• Kohler, C. A., Magalhaes, T. F., Oliveira, J. M., Alves, G. S., Knochel, C., Oertel-Knochel, V., … Carvalho, A. F. (2016). Neuropsychiatric disturbances in Mild Cognitive Impairment (MCI): A systematic review of population-based studies. Current Alzheimer Research, 13(10), 1066–1082.
   PubMed Web of Science ®Google Scholar
• Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Helkala, E. L., Haapala, I., … Rauramaa, R. (2007). Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dementia and Geriatric Cognitive Disorders, 23(1), 29–34.
   PubMed Web of Science ®Google Scholar
• Lai, K. S. P., Liu, C. S., Rau, A., Lanctot, K. L., Kohler, C. A., Pakosh, M., … Herrmann, N. (2017). Peripheral inflammatory markers in Alzheimer's disease: A systematic review and meta-analysis of 175 studies. Journal of Neurology, Neurosurgery and Psychiatry, 88(10), 876–882.
   PubMed Web of Science ®Google Scholar
• Laws, K. R., Irvine, K., & Gale, T. M. (2016). Sex differences in cognitive impairment in Alzheimer's disease. World Journal of Psychiatry, 6(1), 54–65.
   PubMed Web of Science ®Google Scholar
• Levine, G. N., Keaney, J. F., Jr., & Vita, J. A. (1995). Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. New England Journal of Medicine, 332(8), 512–521.
   PubMed Web of Science ®Google Scholar
• Levitt, A. J., & Karlinsky, H. (1992). Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatrica Scandinavica, 86(4), 301–305.
   PubMed Web of Science ®Google Scholar
• Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H., & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nature Reviews. Neurology, 9(2), 106–118.
   PubMed Web of Science ®Google Scholar
• Ma, C., Yin, Z., Zhu, P., Luo, J., Shi, X., & Gao, X. (2017). Blood cholesterol in late-life and cognitive decline: A longitudinal study of the Chinese elderly. Molecular Neurodegeneration, 12(1), 24.
   PubMedGoogle Scholar
• Ma, F., Wu, T., Zhao, J., Song, A., Liu, H., Xu, W., & Huang, G. (2016). Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI. Scientific Reports, 6, 37486.
   PubMed Web of Science ®Google Scholar
• Mack, W. J., Freed, D. M., Williams, B. W., & Henderson, V. W. (1992). Boston Naming Test: Shortened versions for use in Alzheimer's disease. Journal of Gerontology, 47(3), P154–158.
   PubMedGoogle Scholar
• Mattson, M. P., & Shea, T. B. (2003). Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neurosciences, 26(3), 137–146.
   PubMed Web of Science ®Google Scholar
• McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939–944.
   PubMed Web of Science ®Google Scholar
• Meng, X., & D'Arcy, C. (2012). Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses. PLoS One, 7(6), e38268.
   PubMed Web of Science ®Google Scholar
• Miller, K. J., Rogers, S. A., Siddarth, P., & Small, G. W. (2005). Object naming and semantic fluency among individuals with genetic risk for Alzheimer’s disease. International Journal of Geriatric Psychiatry, 20, 128–136.
   PubMed Web of Science ®Google Scholar
• Monsch, A. U., Bondi, M. W., Butters, N., Salmon, D. P., Katzman, R., & Thal, L. J. (1992). Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Archives of Neurology, 49(12), 1253–1258.
   PubMed Web of Science ®Google Scholar
• Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414.
   PubMed Web of Science ®Google Scholar
• Morris, M. S., Selhub, J., & Jacques, P. F. (2012). Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. Journal of the American Geriatric Society, 60(8), 1457–1464.
   PubMed Web of Science ®Google Scholar
• Muthén, B., & Kaplan, D. (1985). A comparison of some methodologies for the factor analysis of non-normal Likert variables. British Journal of Mathematical and Statistical Psychology, 38(2), 171–189.
   Web of Science ®Google Scholar
• Noonan, K. A., Pryer, L. R., Jones, R. W., Burns, A. S., & Lambon Ralph, M. A. (2012). A direct comparison of errorless and errorful therapy for object name relearning in Alzheimer's disease. Neuropsychological Rehabilitation, 22(2), 215–234.
   PubMed Web of Science ®Google Scholar
• Nunes, S. O., Piccoli de Melo, L. G., Pizzo de Castro, M. R., Barbosa, D. S., Vargas, H. O., Berk, M., & Maes, M. (2015). Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. Journal of Affective Disorders, 172, 55–62.
   PubMed Web of Science ®Google Scholar
• Patricacou, A., Psallida, E., Pring, T., & Dipper, L. (2007). The Boston Naming Test in Greek: Normative data and the effects of age and education on naming. Aphasiology, 21(12).
   Web of Science ®Google Scholar
• Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194.
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001). Practice parameter: early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56(9), 1133–1142.
   PubMed Web of Science ®Google Scholar
• Pollman, S., Haupt, M., & Kurz, A. (1995). Changes of the relative severity of naming, fluency and recall impairment in the course of dementia of the Alzheimer type. Dementia, 6(5), 252–257.
   PubMedGoogle Scholar
• Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., Haan, M. N., Green, R., & Miller, J. W. (2005). Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. American Journal of Clinical Nutrition, 82(6), 1346–1352.
   PubMed Web of Science ®Google Scholar
• Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annual Review of Medicine, 47, 387–400.
   PubMed Web of Science ®Google Scholar
• Won, S. R., Yoon, J. H., & Na, D. L. (2017). Characteristics of confrontation naming ability according to word frequency in patients with amnestic mild cognitive impairment: A preliminary study. Communication Sciences & Disorders, 22(2), 177–189.
   Google Scholar
• Salmon, D. P., Butters, N., & Chan, A. S. (1999). The deterioration of semantic memory in Alzheimer's disease. Canadian Journal of Experimental Psychology, 53(1), 108–117.
   PubMed Web of Science ®Google Scholar
• Sekler, A., Jimenez, J. M., Rojo, L., Pastene, E., Fuentes, P., Slachevsky, A., & Maccioni, R. B. (2008). Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatric Disease and Treatment, 4(4), 715–722.
   PubMedGoogle Scholar
• Silagi, M. L., Bertolucci, P. H. F., & Ortiz, K. Z. (2015). Naming ability in patients with mild to moderate Alzheimer's disease: What changes occur with the evolution of the disease? Clinics, 70(6), 423–428.
   PubMed Web of Science ®Google Scholar
• Small, B. J., Rosnick, C. B., Fratiglioni, L., & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology Aging, 19(4), 592–600.
   PubMed Web of Science ®Google Scholar
• Small, J. A., & Sandhu, N. (2008). Episodic and semantic memory influences on picture naming in Alzheimer's disease. Brain and Language, 104(1), 1–9.
   PubMed Web of Science ®Google Scholar
• Spielberg, J. M., Sadeh, N., Leritz, E. C., McGlinchey, R. E., Milberg, W. P., Hayes, J. P., & Salat, D. H. (2017). Higher serum cholesterol is associated with intensified age-related neural network decoupling and cognitive decline in early- to mid-life. Human Brain Mapping, 38(6), 3249–3261.
   PubMed Web of Science ®Google Scholar
• Spindler, A. A., & Renvall, M. A. (1989). Nutritional status and psychometric test scores in cognitively impaired elders. Annals of the New York Academy of Sciences, 561, 167–177.
   PubMed Web of Science ®Google Scholar
• Tariot, P. N., Mack, J. L., Patterson, M. B., Edland, S. D., Weiner, M. F., Fillenbaum, G., … Ceará (1995). The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. The American Journal of Psychiatry, 152(9), 1349–1357.
   PubMed Web of Science ®Google Scholar
• Thai Cognitive Test Development Committee. (2002). Mini-Mental State Examination-Thai 2002. Bangkok: Institute of Geriatric Medicine, Department of Medical Services, Ministry of Public Health, Thailand.
   Google Scholar
• Toro, P., Degen, C., Pierer, M., Gustafson, D., Schroder, J., & Schonknecht, P. (2014). Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. European Archives of Psychiatry and Clinical Neuroscience, 264(6), 485–492.
   PubMed Web of Science ®Google Scholar
• van der Vlies A. E., Pijnenburg Y. A., Koene T., Klein M., Kok A., Scheltens P., & van der Flier, W. M. (2007). Cognitive impairment in Alzheimer's disease is modified by APOE genotype. Dementia and Geriatric Cognitive Disorders, 24, 98–103.
   PubMed Web of Science ®Google Scholar
• Van Gorp, W. G., Satz, P., Kiersch, M. E., & Henry, R. (1986). Normative data on the Boston Naming Test for a group of normal older adults. Journal of Clinical and Experimental Neuropsychology, 8(6), 702–705.
   PubMed Web of Science ®Google Scholar
• Viswanathan, A., & Greenberg, S. M. (2011). Cerebral amyloid angiopathy in the elderly. Annals of Neurology, 70(6), 871–880.
   PubMed Web of Science ®Google Scholar
• Welch, L. W., Doineau, D., Johnson, S., & King, D. (1996). Educational and gender normative data for the Boston Naming Test in a group of older adults. Brain and Language, 53(2), 260–266.
   PubMed Web of Science ®Google Scholar
• Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology, 44(4), 609–614.
   PubMed Web of Science ®Google Scholar
• Whalley, L. J., Deary, I. J., Appleton, C. L., & Starr, J. M. (2004). Cognitive reserve and the neurobiology of cognitive aging. Ageing Research Reviews, 3(4), 369–382.
   PubMed Web of Science ®Google Scholar
• Willers, I. F., Feldman, M. L., & Allegri, R. F. (2008). Subclinical naming errors in mild cognitive impairment: A semantic deficit? Dementia & Neuropsychologia, 2, 217–222.
   PubMedGoogle Scholar